MOUNT LAUREL, N.J., June 3 /PRNewswire-FirstCall/ -- MedQuist Inc. today announced the appointment of Mark Ivie as its new chief technology officer. He will join MedQuist on June 27. Ivie comes to the company with more than 20 years of experience managing large development teams in tier-one companies. He has a proven track record of delivering technology solutions to the market, driving the overall success of the business.
Ivie has strong healthcare IT experience, including healthcare clinical solutions and workflows. He was most recently the general manager, Enterprise Systems and Technology for GE Healthcare, where he was responsible for the creation and adoption of standards, and for creating the infrastructure for sharing functional and infrastructure models. During his tenure at GE, he was responsible for the integration of six acquisitions into a single clinical information system, helping increase the business from $50 million to more than $495 million in just five years.
Prior to that position, Ivie held positions at both Lucent Bell Laboratories and AT&T Bell Laboratories. While at Lucent, he grew their telecom support software business from $6 million to $70 million, captured all major and most U.S. telecom providers as customers, and increased the engineering team from 25 to 150. He also managed integrated work in six other organizations across four states and three countries to produce synchronized, integrated deliverables.
MedQuist, a member of the Philips Group of Companies, is a leading provider of electronic medical transcription, health information and document management products and services. MedQuist provides document workflow management, digital dictation, speech recognition, mobile dictation devices, Web-based transcription, electronic signature, medical coding products and outsourcing services.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist’s business which are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward- looking statements, see “Risk Factors” in the Company’s Annual Report or Form 10-K for the fiscal year ending December 31, 2002.
MedQuist Inc.
CONTACT: Leeann Essai, Director, Marketing Communications, MedQuist Inc.,+1-856-206-4700, lessai@medquist.com
Web site: http://www.medquist.com/
